A two-stage thermal desorption/secondary electrospray ionisation/time-of-flight mass spectrometry for faster targeted breath profiling has been studied. A new secondary electrospray ionisation (SESI) source was devised to constrain the thermal desorption plume and promote efficient mixing in the ionization region. Further a chromatographic pre-separation stage was introduced to suppress interferences from siloxanes associated with thermal desorption profiles of exhaled breath samples.
Introduction
In 1986 Fenn et al. noted the efficient electrospray ionisation (ESI) of volatile organic compounds (VOC) 1, 2 Hill et al. subsequently interfaced an ESI source to an ion mobility spectrometer, 3 and went on to show how VOC product ions could be generated by ESI for ion mobility spectrometry (IMS) determination and used the term secondary electrospray ionisation (SESI) 4 to describe this process. The potential sensitivity of SESI was evident in the early descriptions of SESI with Hill and co-workers reporting a well-defined response (s/n >20) for cocaine from a mass flux of ca. 1 pg.s -1 .
In SESI-IMS the electrospray plume was directed into the reaction region of an ion mobility spectrometer that contained sampled narcotic vapours. The high-sensitivity of SESI was combined with a quadrupole-time-of-flight mass spectrometer (ToFMS), operating in the negative mode, to profile volatile fatty acids in exhaled breath samples. 5 Here, saturated and unsaturated fatty acids ranging from C3 to C14 in length were isolated at estimated concentrations in the order of 100 pptv; indicative of a highsensitivity assay. More recently, volatile fatty acid profiling has been used to identify individuals from a cohort of 65 participants with a global recognition score of 63% (43 out of 65 correct) which suggests that this approach has the potential to distinguish and identify specific metabolic phenotypes. 6 Similarly, Cooks et al. described extractive electrospray ionisation (EESI) 7 based on mixing aerosol from a nebulised sample spray with an electrospray plume. The resultant interactions between electrospray droplets, ions and the aerosolised solution of analytes efficiently generated analyte ions. The potential utility of EESI was first demonstrated in a study that screened urine, surface waters and milk for trace-levels of pesticides and explosives. This study was a significant development in that proof-of-concept data were presented that highlighted high-speed quantitative assays of complex mixtures with substantial reductions in the resources, time and skill required to achieve high-fidelity analytical outcomes. The sensitivity of the approach and its tolerance of complex matrices was illustrated through the detection of 1 pmol of 1,3,5-trinitroperhydro-1,3,5triazine (RDX) spiked into undiluted mouse urine and 1 pmol of trinitrotoluene (TNT) spiked into polluted river water; based on EESI analysis without sample clean-up. The direct detection of volatile potentially genotoxic impurities by thermal desorption EESI combined with MS and IMS-MS has also been reporte. 8 , 9 Coupling a gas chromatograph to an electrospray mass spectrometer has also been accomplished adding in a hyphenated separation to resolve complex mixtures. This was demonstrated using a multiple channel (7 emitter) ESI source in 1998, 10 here the GC outlet was directed into the central electrospray emitter enabling eluted analytes to interact with the solvent before being electrosprayed. This novel approach was able to detect acylated aliphatic acids and was used to monitor a dehydrogenation of dimethylhydrazine in real-time. The combination of EESI-MS and atmospheric pressure chemical ionization (APCI-MS) with gas chromatography was used to detect a range of volatile organic compounds including pyridine, aminopyridine, n-vinylpyridine and the controlled substances 3,4methylenedioxy-N-methylamphetamine (MDMA) and 3,4-methylenedioxy-Nethylamphetamine (MDEA) by Brenner et. al. in 2008. 11 Limits of detection for the pyridines were determined to be in the low picomole range indicating the sensitivity of the technique.
Breath profiling is an increasingly important approach to aid clinicians in diagnosing disease. Due to the non-invasive manner in which samples are collected, taking a breath sample can be part of a routine medical examination, giving it the potential to be used as a screening method for large populations. The importance of breath sampling and its capability to identify biomarkers for different diseases has been the subject of a number of review articles which highlight developments in clinical breath profiling. [12] [13] [14] [15] Breath sampling can be accomplished either offline using established lab-based techniques such as GC and GCxGC-ToFMS 16 which can be coupled to preconcentration techniques such as thermal desorption to enable high resolution measurements on low concentration breath metabolites. The development of techniques such as proton transfer reaction-mass spectrometry (PTR-MS) 17 and selected ion flow tube -mass spectrometry (SIFT-MS) 18 has enabled monitoring of highly volatile species in real-time, providing diagnostic data in a very short timescale, however these techniques are less useful for the analysis of larger, less volatile species.
The extension of EESI-MS to exhaled breath profiling 19-24 was a logical development since it enables faster analysis times than GC-MS, while maintaining the ability to detect semivolatile species solvated in aerosol particles. In 2007 EESI was used for breath-by-breath monitoring of exhaled urea concentration. 19 In the same year EESI was used to ionise non-volatile components such as carbohydrates in breath, thereby bridging the previously disparate approaches of exhaled breath condensate analysis and exhaled breath analysis. 20 In a study of the breath of smokers, nicotine was detected at 50 pg m -3 using EESI. 21 Translational research has used SESI-MS to monitor the pharmacokinetic behaviour of the epilepsy drug valproic acid with an on-line breath sampler interfaced to a electrospray source enabling the exhaled-breath concentration of valproic acid, and its metabolites/catabolites, to be tracked continuously with the result that the elimination profile of the drug was described in a non-invasive manner. 24 The sensitivity and general applicability of ESI techniques for VOC analysis continue to be developed for a variety of mass spectrometer interfaces, and estimates for limits-of-detection (LOD) continue to be reported at ever diminishing levels'; recently claimed to be in the order of 28 fmol s -1 for cocaine. 22 A study with 6 probe VOCs (methyl decanoate, octan-3-one, 2-ethylhexanoic acid, 1,4-diaminobutane, dimethyl methylphosphonate, and 2,3-butanediol), using a triple quadrupole mass spectrometer highlighted the importance of the operating parameters of the ionisation sources on the sensitivity of the analytical response with some indication that detection in the ppqv to pptv range was attainable. 23 Such developments suggest that the limiting factors for trace-quantitation of VOC by ESI-MS are as likely to be associated with the challenge of generating VOC concentrations,
reproducibly, at ppt(v) and lower, as with the design and optimisation of the ionisation and mass-spectrometric processes.
It is helpful to note that GC-MS analysis of human breath has revealed a chemically complicated mixture with hundreds of VOC routinely isolated over approximately fourorders of magnitude of concentration, and many of these compounds may only be detected if preconcentration approaches are adopted. 25 There are a number of strategies for accomplishing preconcentration of volatiles before mass spectrometric analysis including thermal desorption (TD), 25-27 solid-phase microextraction (SPME) 28 and needle trap devices (NTD). 29 These technologies have been used to take samples in clinical settings in conjunction with portable instrumentation. 29 Thermal desorption with coldtrapping followed by recovery by ballistic heating (referred to as two-stage thermal desorption) of VOC retained within adsorbent media is used widely with GC-MS instrumentation attaining 10 4 to 10 5 enrichment. [25] [26] [27] As well as the advantages of preconcentration, the adsorbent tubes used in TD approaches are portable, enabling large numbers of of breath samples to be taken at remote locations, and then returned to the laboratory for analysis. VOC trapped on sampling adsorbents are stable enough to be stored prior to analysis, although exactly for how long has yet to be established.
Importantly, adsorbent tubes enable sterile single use and clinically safe sampling systems to be used to collect exhaled breath 30 at the bedside, within the clinic or in the community. Previously the analysis of exhaled breath samples from human volunteer participants using a thermal desorption system hyphenated to a Waters Synapt HDMS ion-mobility mass spectrometer was described. 31 With typical analysis times of 12 minutes per sample claimed, the advantages of eliminating a lengthy GC separation stage (analysis times typically up to 90 min) for in-clinic applications were self-evident.
In the current work the ionisation efficiency of the low concentration VOC components recovered by thermal desorption from sampled breath was studied. Two factors were TD-ESI-MS Table 1 summarises the operational parameters of the instrument systems. The thermal desorption was operated without a split with a 1 min pre-purge at a temperature of 300ºC for 5 min to a cold trap maintained at -10°C that concentrated the thermally desorbed volatiles. Injection was by ballistic heating of the cold-trap at 50 ºC s -1 to 300 ºC; maintained for 3 min. The transfer line was maintained at 120º C, and the desorption flow through the cold-trap and transfer-line was 5 cm 3 min -1 of purified helium.
The mass spectrometer (Synapt HDMS Waters, Manchester, UK) was operated with the ion mobility function disabled. All experiments were performed in the positive ion mode over a mass range of m/z 50 to m/z 500.
Results and Discussion
The effect of a constrained source.
The the two sources reveals that the constrained SESI source with pre-separation resulted in significant increases in the number of ions observed at low concentrations, see Figure 4 .
In Figure 4 the mass spectra in Figure 3 were characterised in terms of the total number of analytical features (peaks) observed over a given normalised intensity range. For 97.5% of the normalised intensity range from 0.025 upwards to 1 the distributions of the number of mass spectral peaks observed was essentially the same for both approaches.
However what was clear was that the greatest number of analytical features were to be observed at the lowest intensities. Significantly more analytical features were observed using the constrained SESI source with pre-separation. The open SESI without preseparation yielded 260 mass spectral peaks, of which 179, (69%) were present at a normalised intensity of equal to or less than 0.025. In contrast the constrained source yielded 541 peaks, with 448 (83%) present at intensities equal to or less than a normalised intensity of 0.025.
Reproducibility
Reproducibility measurements were based on 20 replicate breath samples collected sequentially from a healthy volunteer. 10 samples selected randomly were analysed by each of the techniques and the reproducibility compared. 
Clinical pilot
The final test undertaken was a pilot study to assess the feasibility of adopting this approach for targeted breath profiling. 17 exhaled breath samples were obtained from volunteers attending or working at a severe asthma clinic (Glenfield Hospital, Leicester, UK). 10 samples were analysed by TD-SESI-ToFMS with a constrained source with preseparation and 7 were analysed with TD-SESI-ToFMS with an open source and no preseparation. 11 VOC, reported previously in breath profiling studies of respiratory disease 36-39 , were selected as target compounds and the thermal desorption profiles were screened in the positive mode for protonated product ions. Table 2 is a summary of the endogenous breath VOC identification from the two sets of data. It was not always possible to obtain accurate mass measurements (<15 ppm) in the absence of a low m/z lock mass ion. The constrained source with pre-separation enabled 1-hydroxyacetone, 3-buten-2-one, and acetone to be observed in all samples. In those instances when it was possible to assign ions on the basis of accurate mass (to within 15 ppm of the monoisotopic mass), the thermal desorption profile was integrated and the mean responses in Table 2 indicate that the constrained source with preseparation resulted in a higher proportion of accurate masses and more sensitive responses. to develop the ionisation systems for VOC that do not form ions in a SESI source, so that these species can be included in this approach. Mass spectra (bottom), and their cumulative distribution functions, (F(x) vs. m/z from breath samples taken from the same participant, at approximately the same time illustrating the effect of constraining the SESI source with pre-separation on the resultant data. The large siloxane responses were effectively supressed, and their distortion of the cumulative distribution function eliminated. Note the increased chemical space associated with the constrained SESI source with preseparation; arising from a significant increase in number of lower intensity signals observed, see Figure 4 . 
Conclusions

